Results 11 to 20 of about 111,478 (253)
Medical Clinics of North America, 1988 Potent effective antiviral drugs recently have been licensed for several viral diseases, ushering in a new era in the treatment of viral diseases. Several unique features in the process of a viral infection have been identified as target points for inhibition. The unique steps and the interfering compounds are the subject of this review.
Reines, Eric D., Gross, Peter A.
openaire +2 more sources
Amantadine: an antiviral and antiparkinsonian agent
Veterinární Medicína, 2001 Amantadine is an antiviral agent that specifically inhibits influenza A virus replication at a micromolar concentration. This drug is also very effective in the treatment of human Parkinson's disease.
J. Staničová +2 more
doaj +1 more source
Antiviral Activities of Algal-Based Sulfated Polysaccharides
Molecules, 2022 An antiviral agent is urgently needed based on the high probability of the emergence and re-emergence of future viral disease, highlighted by the recent global COVID-19 pandemic. The emergence may be seen in the discovery of the Alpha, Beta, Gamma, Delta,
Jonathan Ardhianto Panggabean +6 more
doaj +1 more source
Viruses, 2020 Dengue virus (DENV) infection has become a critically important globally prevalent infectious disease, especially in tropical and subtropical countries.
Aussara Panya +6 more
doaj +1 more source
Molecules, 2020 A catalytic and enantioselective preparation of the (S)-4-methyleneproline scaffold is described. The key reaction is a one-pot double allylic alkylation of an imine analogue of glycine in the presence of a chinchonidine-derived catalyst under phase ...
Blanca López +6 more
doaj +1 more source
Ribonucleases as antiviral agents [PDF]
Molecular Biology, 2014 Many ribonucleases (RNases) are able to inhibit the reproduction of viruses in infected cell cultures and laboratory animals, but the molecular mechanisms of their antiviral activity remain unclear. The review discusses the well-known RNases that possess established antiviral effects, including both intracellular RNases (RNase L, MCPIP1 protein, and ...
Ilinskaya O., Mahmud R.
openaire +4 more sources
Mosquito-Borne Flaviviruses and Current Therapeutic Advances
Viruses, 2022 Mosquito-borne flavivirus infections affect approximately 400 million people worldwide each year and are global threats to public health. The common diseases caused by such flaviviruses include West Nile, yellow fever, dengue, Zika infection and Japanese
Xijing Qian, Zhongtian Qi
doaj +1 more source
Multi-Omics Studies towards Novel Modulators of Influenza A Virus–Host Interaction
Viruses, 2016 Human influenza A viruses (IAVs) cause global pandemics and epidemics. These viruses evolve rapidly, making current treatment options ineffective.
Sandra Söderholm +11 more
doaj +1 more source
, 2009 Antiviral agents are drugs approved in the USA by the Food and Drug Administration (FDA) for the treatment or control of viral infections. Available antiviral agents mainly target stages in the viral life cycle. The target stages in the viral life cycle are; viral attachment to host cell, uncoating, synthesis of viral mRNA, translation of mRNA ...
Paintsil, E., Cheng, Yung-Chi
openaire +2 more sources
Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide [PDF]
Clinical and Molecular HepatologyBackground/Aims Tenofovir disoproxil fumarate (TDF) is known to have a lipid-lowering effect. This is in contrast to tenofovir alafenamide (TAF), which has a lipid-neutral effect.
Hyeyeon Hong +7 more
doaj +1 more source